Hackensack Meridian Health Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2014
NCT02182622
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

HMH-JFK

Active Ingredients

Drugs in Phase 1 Trials (3)

docetaxel (taxotere) (1 trial)

prednisone (meticorten) (1 trial)

sonidegib (odomzo) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Disease Progression (Phase 1)

Prostatic Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 3